vs
Side-by-side financial comparison of APTARGROUP, INC. (ATR) and MARRIOTT VACATIONS WORLDWIDE Corp (VAC). Click either name above to swap in a different company.
MARRIOTT VACATIONS WORLDWIDE Corp is the larger business by last-quarter revenue ($1.2B vs $962.7M, roughly 1.3× APTARGROUP, INC.). APTARGROUP, INC. runs the higher net margin — 7.7% vs -35.0%, a 42.7% gap on every dollar of revenue. On growth, APTARGROUP, INC. posted the faster year-over-year revenue change (13.5% vs -0.7%). APTARGROUP, INC. produced more free cash flow last quarter ($96.9M vs $-6.0M). Over the past eight quarters, MARRIOTT VACATIONS WORLDWIDE Corp's revenue compounded faster (5.2% CAGR vs 2.6%).
AptarGroup, Inc., also known as Aptar, is a United States–based global manufacturer of consumer dispensing packaging and drug delivery devices. The group has manufacturing operations in 18 countries.
Marriott Vacations Worldwide Corporation is a pure-play public timeshare company. Formerly a division of Marriott International, Marriott Vacations Worldwide was established as a separate, publicly traded entity focusing primarily on vacation ownership in November 2011. Marriott Vacations Worldwide runs more than 120 resorts with over 700,000 Owners and members in a diverse portfolio of brands under The Marriott Vacation Clubs name. Its brands include Marriott Vacation Club, The Marriott Vaca...
ATR vs VAC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $962.7M | $1.2B |
| Net Profit | $74.3M | $-431.0M |
| Gross Margin | — | — |
| Operating Margin | 11.0% | — |
| Net Margin | 7.7% | -35.0% |
| Revenue YoY | 13.5% | -0.7% |
| Net Profit YoY | -26.4% | -962.0% |
| EPS (diluted) | $1.13 | $-12.00 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $962.7M | $1.2B | ||
| Q3 25 | $961.1M | $1.2B | ||
| Q2 25 | $966.0M | $1.2B | ||
| Q1 25 | $887.3M | $1.1B | ||
| Q4 24 | $848.1M | $1.2B | ||
| Q3 24 | $909.3M | $1.2B | ||
| Q2 24 | $910.1M | $1.1B | ||
| Q1 24 | $915.4M | $1.1B |
| Q4 25 | $74.3M | $-431.0M | ||
| Q3 25 | $127.9M | $-2.0M | ||
| Q2 25 | $111.7M | $69.0M | ||
| Q1 25 | $78.8M | $56.0M | ||
| Q4 24 | $100.9M | $50.0M | ||
| Q3 24 | $100.0M | $84.0M | ||
| Q2 24 | $90.5M | $37.0M | ||
| Q1 24 | $83.1M | $47.0M |
| Q4 25 | 11.0% | — | ||
| Q3 25 | 14.2% | — | ||
| Q2 25 | 14.9% | — | ||
| Q1 25 | 12.8% | — | ||
| Q4 24 | 14.2% | — | ||
| Q3 24 | 15.2% | — | ||
| Q2 24 | 13.8% | — | ||
| Q1 24 | 12.2% | — |
| Q4 25 | 7.7% | -35.0% | ||
| Q3 25 | 13.3% | -0.2% | ||
| Q2 25 | 11.6% | 6.0% | ||
| Q1 25 | 8.9% | 5.0% | ||
| Q4 24 | 11.9% | 4.0% | ||
| Q3 24 | 11.0% | 6.9% | ||
| Q2 24 | 9.9% | 3.5% | ||
| Q1 24 | 9.1% | 4.2% |
| Q4 25 | $1.13 | $-12.00 | ||
| Q3 25 | $1.92 | $-0.07 | ||
| Q2 25 | $1.67 | $1.77 | ||
| Q1 25 | $1.17 | $1.46 | ||
| Q4 24 | $1.48 | $1.29 | ||
| Q3 24 | $1.48 | $2.12 | ||
| Q2 24 | $1.34 | $0.98 | ||
| Q1 24 | $1.23 | $1.22 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $409.5M | $406.0M |
| Total DebtLower is stronger | $1.1B | — |
| Stockholders' EquityBook value | $2.7B | $2.0B |
| Total Assets | $5.3B | $9.8B |
| Debt / EquityLower = less leverage | 0.43× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $409.5M | $406.0M | ||
| Q3 25 | $264.8M | $474.0M | ||
| Q2 25 | $169.8M | $205.0M | ||
| Q1 25 | $136.8M | $196.0M | ||
| Q4 24 | $226.2M | $197.0M | ||
| Q3 24 | $327.9M | $197.0M | ||
| Q2 24 | $223.9M | $206.0M | ||
| Q1 24 | $201.1M | $237.0M |
| Q4 25 | $1.1B | — | ||
| Q3 25 | $546.0M | — | ||
| Q2 25 | $535.1M | — | ||
| Q1 25 | $561.2M | — | ||
| Q4 24 | $688.1M | — | ||
| Q3 24 | $822.7M | — | ||
| Q2 24 | $681.5M | — | ||
| Q1 24 | $680.4M | — |
| Q4 25 | $2.7B | $2.0B | ||
| Q3 25 | $2.8B | $2.5B | ||
| Q2 25 | $2.7B | $2.5B | ||
| Q1 25 | $2.5B | $2.4B | ||
| Q4 24 | $2.5B | $2.4B | ||
| Q3 24 | $2.5B | $2.4B | ||
| Q2 24 | $2.4B | $2.4B | ||
| Q1 24 | $2.3B | $2.4B |
| Q4 25 | $5.3B | $9.8B | ||
| Q3 25 | $5.1B | $10.1B | ||
| Q2 25 | $4.9B | $9.9B | ||
| Q1 25 | $4.5B | $9.9B | ||
| Q4 24 | $4.4B | $9.8B | ||
| Q3 24 | $4.6B | $9.7B | ||
| Q2 24 | $4.5B | $9.6B | ||
| Q1 24 | $4.4B | $9.9B |
| Q4 25 | 0.43× | — | ||
| Q3 25 | 0.20× | — | ||
| Q2 25 | 0.20× | — | ||
| Q1 25 | 0.22× | — | ||
| Q4 24 | 0.28× | — | ||
| Q3 24 | 0.32× | — | ||
| Q2 24 | 0.28× | — | ||
| Q1 24 | 0.29× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $183.7M | $6.0M |
| Free Cash FlowOCF − Capex | $96.9M | $-6.0M |
| FCF MarginFCF / Revenue | 10.1% | -0.5% |
| Capex IntensityCapex / Revenue | 9.0% | 1.0% |
| Cash ConversionOCF / Net Profit | 2.47× | — |
| TTM Free Cash FlowTrailing 4 quarters | $299.6M | $-29.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $183.7M | $6.0M | ||
| Q3 25 | $177.6M | $62.0M | ||
| Q2 25 | $126.0M | $-48.0M | ||
| Q1 25 | $82.7M | $8.0M | ||
| Q4 24 | $178.2M | $100.0M | ||
| Q3 24 | $229.3M | $72.0M | ||
| Q2 24 | $143.6M | $30.0M | ||
| Q1 24 | $92.3M | $3.0M |
| Q4 25 | $96.9M | $-6.0M | ||
| Q3 25 | $114.3M | $51.0M | ||
| Q2 25 | $62.5M | $-68.0M | ||
| Q1 25 | $25.9M | $-6.0M | ||
| Q4 24 | $112.2M | $86.0M | ||
| Q3 24 | $162.7M | $58.0M | ||
| Q2 24 | $75.4M | $17.0M | ||
| Q1 24 | $16.7M | $-13.0M |
| Q4 25 | 10.1% | -0.5% | ||
| Q3 25 | 11.9% | 4.3% | ||
| Q2 25 | 6.5% | -5.9% | ||
| Q1 25 | 2.9% | -0.5% | ||
| Q4 24 | 13.2% | 6.9% | ||
| Q3 24 | 17.9% | 4.8% | ||
| Q2 24 | 8.3% | 1.6% | ||
| Q1 24 | 1.8% | -1.2% |
| Q4 25 | 9.0% | 1.0% | ||
| Q3 25 | 6.6% | 0.9% | ||
| Q2 25 | 6.6% | 1.7% | ||
| Q1 25 | 6.4% | 1.3% | ||
| Q4 24 | 7.8% | 1.1% | ||
| Q3 24 | 7.3% | 1.1% | ||
| Q2 24 | 7.5% | 1.2% | ||
| Q1 24 | 8.3% | 1.4% |
| Q4 25 | 2.47× | — | ||
| Q3 25 | 1.39× | — | ||
| Q2 25 | 1.13× | -0.70× | ||
| Q1 25 | 1.05× | 0.14× | ||
| Q4 24 | 1.77× | 2.00× | ||
| Q3 24 | 2.29× | 0.86× | ||
| Q2 24 | 1.59× | 0.81× | ||
| Q1 24 | 1.11× | 0.06× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ATR
| Pharma Segment | $833.1M | 87% |
| Other | $129.6M | 13% |
VAC
| Cost Reimbursement | $467.0M | 38% |
| Time Share | $381.0M | 31% |
| Management And Exchange | $212.0M | 17% |
| Ancillary Revenues | $64.0M | 5% |
| Management Service | $55.0M | 4% |
| Service Other | $36.0M | 3% |
